Onyx Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

iCD Research
February 6, 2012
33 Pages - SKU: ICDR6793014
License type:
Table of Contents Search inside this report Related Reports
Synopsis

ICD Research's Onyx Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's Onyx Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Onyx Pharmaceuticals, Inc..

ICD Research's Onyx Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Onyx Pharmaceuticals, Inc. for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance.
  • The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Onyx Pharmaceuticals, Inc. .
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company engaged in developing product candidates for the treatment of indications in oncology on the basis of its proprietary virus technology. The company is developing innovative therapies, which target the molecular mechanisms that cause cancer. Its lead product is Nexavar tablet, a novel, oral multiple kinase inhibitors used for the treatment of kidney and liver cancers. The product, Nexavar, has gained approval in 90 countries for treating patients having unresectable liver cancer, and in over 95 countries for treating patients with advanced kidney cancer. Its other focus areas include proteasome inhibition development. The company is headquartered in Emeryville, California, the US.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Pharmaceuticals Company Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!